SUCCESSOR-2
A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480 (BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
Near Add Your Location
Sorting 38 by
OhioHealth Riverside Methodist Hospital
Columbus, OH
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Northwest Medical Specialties (Gig Harbor)
Gig Harbor, WA
- Accepting patients
- Show Principal Investigator
Kaiser Permanente Orange County
Irvine Medical Center
Irvine, CA
This trial location is only accepting patients with Kaiser Permanente Insurance.
- Accepting patients
- Show Principal Investigator
Augusta University Medical Center
Augusta, GA
- Accepting patients
- Show Principal Investigator
Houston Methodist Hospital
Houston, TX
- Accepting patients
- Show Principal Investigator
Los Angeles Cancer Network (Los Angeles)
Los Angeles, CA
- Accepting patients
Montefiore Medical Center
Bronx, NY
- Accepting patients
- Accepting patients
- Show Principal Investigator
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.